Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yieldFilipe Montes de Jesus, Walter Noordzij, Thomas C. Kwee et al.|European Journal of Nuclear Medicine and Molecular Imaging|2019Cited by 24
First-in-Human Study of the CD123 NK Cell Engager SAR443579 in Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia or High Risk-Myelodysplasia: Updated Safety, Efficacy, Pharmacokinetics and PharmacodynamicsAshish Bajel, Anthony S. Stein, Sylvain Garciaz et al.|Blood|2023Cited by 24
Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profileLotte E. van der Wagen, Jürgen Kuball, Magdalena J. Lorenowicz et al.|Bone Marrow Transplantation|2020Cited by 18
P494: A FIRST-IN-HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK-MYELODYSPLASIAAnthony S. Stein, Ashish Bajel, Gu Mi et al.|HemaSphere|2023Cited by 2